Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER‐2 cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER‐2 cohort study

Published:2022-01-10 Issue: Volume: Page:
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG

Author:

Sundar Sudha¹²^ORCID,Cummins Carole³,Kumar Satyam³^ORCID,Long Joanna³,Arora Vivek⁴,Balega Janos²,Broadhead Tim⁵,Duncan Tim⁶,Edmondson Richard⁷^ORCID,Fotopoulou Christina⁸,Glasspool Ros⁹,Kolomainen Desiree¹⁰,Leeson Simon¹¹,Manchanda Ranjit¹²¹³^ORCID,McNally Orla¹⁴,Morrison Jo¹⁵^ORCID,Mukhopadhyay Asima¹⁶,Paul Jim⁹,Tidy John¹⁷^ORCID,Wood Nick¹⁸

Affiliation:

1. Institute of Cancer and Genomic Sciences University of Birmingham Birmingham UK

2. Sandwell and West Birmingham NHS Trust Birmingham UK

3. Institute of Applied Health Research University of Birmingham Birmingham UK

4. Bondi Women's Health Sydney NSW Australia

5. Leeds Teaching Hospitals NHS Trust Leeds UK

6. Norfolk & Norwich University Hospital Norwich UK

7. University of Manchester Manchester UK

8. Imperial College London London UK

9. University of Glasgow Glasgow UK

10. Kings College NHS Foundation Trust London UK

11. Betsi Cadwaladr University Health Board Bangor UK

12. Wolfson Institute of Population Health Queen Mary University of London London UK

13. Department of Health Services Research London School of Hygiene & Tropical Medicine London UK

14. Peter MacCallum Cancer Centre Melbourne Vic. Australia

15. Taunton and Somerset NHS Foundation Trust Taunton UK

16. Tata Medical Center Kolkata India

17. University of Sheffield Sheffield UK

18. Lancashire Teaching Hospitals NHS Foundation Trust Preston UK

Funder

UK-India Education and Research Initiative

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1471-0528.17041

Reference46 articles.

1. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols RF;J Clin Oncol,2003

2. Ovarian cancer;Jayson GC;Lancet,2014

3. Weekly dose‐dense chemotherapy in first‐line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial;Clamp AR;Lancet,2019

4. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference;Stuart GC;Int J Gynecol Cancer,2011

5. Improved progression‐free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm;Chi DS;Gynecol Oncol,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State;Gynecologic Oncology;2024-03

2. Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer—Quality of Life Evaluation Research) Prospective, International, Multicentre Study;Cancers;2023-12-22

3. Health state utility and health-related quality of life measures in patients with advanced ovarian cancer;Gynecologic Oncology Reports;2023-12

4. Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis;Gynecologic Oncology;2023-12

5. Survivorship research in advanced gynecological cancer: A scoping review of cohort studies;Cancer Medicine;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3